Mark Watson-Mitchell: Reflecting on the last six months
On Tuesday 24 March this year we had just suffered one of the worst days of market price drops this year. However, as in life, everything gets overplayed.
On Tuesday 24 March this year we had just suffered one of the worst days of market price drops this year. However, as in life, everything gets overplayed.
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Mark Watson-Mitchell takes a look at an AIM-listed printed circuit specialist.
Robert Stephens, CFA, discusses the prospects for British American Tobacco and GlaxoSmithKline amid an increasingly uncertain economic outlook
Mark Watson-Mitchell considers the outlook for another palm oil producer.
Mark Watson-Mitchell considers the prospects of shares in this AIM-listed challenger consultancy group.
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Robert Stephens, CFA, considers the outlook for BAE and Rolls-Royce amid an uncertain outlook for the aerospace and defence sector.
With gold on, possibly, a bit of a plateau, or even at what some investors might think is a peak, they might be thinking of re-deploying their profits from my gold coverage. But from which stock?
Mark Watson-Mitchell reckons Restore will see a second-half bounce, before doing much better next year.